Open Accessβ-Lactam/β-lactamase inhibitors versus carbapenems for the treatment of sepsis: systematic review and meta-analysis of randomized controlled trials
Author(s) -
Shachaf Shiber,
Dafna Yahav,
Tomer Avni,
Leonard Leibovici,
Mical Paul
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku351
Subject(s) - lactam , meta analysis , medicine , randomized controlled trial , cephalosporin , carbapenem , doripenem , antibiotics , sepsis , microbiology and biotechnology , intensive care medicine , meropenem , chemistry , biology , antibiotic resistance , stereochemistry
Data on the relative efficacy of β-lactam/β-lactamase inhibitors (BL/BLIs) versus carbapenems are scant.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom